Thermo Fisher Scientific (TMO) Free Cash Flow (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Free Cash Flow for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow rose 51.58% year-over-year to $1.7 billion; the trailing twelve-month figure through Jun 2026 stood at $7.3 billion (up 18.61% YoY), and the FY2025 full-year result was $6.3 billion, down 13.4% from the prior year.
• Free Cash Flow grew to $1.7 billion in Q2 2026 per TMO's latest filing, from $816.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $3.3 billion in Q4 2023 and bottomed at $271.0 million in Q2 2023.
• Historically, Free Cash Flow has averaged $1.7 billion across 5 years, with a median of $1.6 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow tumbled 82.65% in 2023, then jumped 233.58% in 2024.
• Over 5 years, Free Cash Flow stood at $2.9 billion in 2022, then increased by 12.97% to $3.3 billion in 2023, then dropped by 15.31% to $2.8 billion in 2024, then gained by 6.48% to $3.0 billion in 2025, then tumbled by 44.02% to $1.7 billion in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $1.7 billion, $816.0 million, and $3.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.